Facebook Twitter RSS Feed

You are here

Practice Management

 - energy drink

Fighting adolescent obesity with a healthy message has sweet effects. Researchers studied how adolescents made purchasing choices after being exposed to four different messages about sugar-sweetened drinks. Some decided against drink purchases altogether, according to the study published online Oct. 16 in the American Journal of Public Health.

 - muffins

For cardiovascular risks, the kind of fat consumed may be as important as how much. In a study published online Oct. 15 in the Journal of the American Heart Association, volunteers had better cardiometabolic markers after seven weeks of consuming muffins baked with sunflower oil compared to those with palm oil. 

 - scratch

More psoriasis sufferers are at risk for elevated blood pressure and uncontrolled hypertension, researchers found. The findings, published online Oct. 15 in JAMA: Dermatology, suggest a dose-response relationship between more severe psoriasis and hypertension compared with patients without psoriasis.

 - doctors talking

Patient outcomes were not poorer when practicing physicians worked fewer residency hours, a study found. Patients whose practicing, post-residency physicians had been affected by 2003’s reduction in residency hours regulations did not have higher rates of mortality or longer hospital stays, according to a study published in the October issue of Health Affairs.

 - patient

Location, location, location. Patients with acute MI who mistakenly were admitted to noncardiology departments were more likely to die before and after discharge than counterparts treated in coronary care units, according to a subanalysis of the DEF-AMI study. Their mortality risk was almost twice as high.


More Stories

Fenoldopam flops in preventing renal replacement therapy after AKI

Fenoldopam was found to be ineffective at reducing risks for renal replacement therapy in cardiovascular patients with acute kidney injury (AKI), according to a study published Sept. 29 in JAMA. It was also ineffective at reducing risk of death over placebo.

CKD does not indicate extra bleeding risks in stroke treatment

Chronic kidney disease (CKD) was not an indicator of increased bleeding risk in stroke patients treated with intravenous thrombolysis, according to a study published online Sept. 23 in Circulation: Cardiovascular Quality and Outcomes. The research team did note that stroke patients with CKD did have increased risks for poorer outcomes, however.

Postoperative cardiac events increased in sleep apnea patients

Obstructive sleep apnea increased rates of postoperative cardiac events, according to a study published in the October issue of Anesthesiology.

Asthma drug elevates cardiovascular risk

The FDA warned that the asthma drug omalizumab slightly increases the risk of cardiovascular and cerebrovascular events in patients treated with the medicine.

Compressions in CPR: Guidelines may need to dial back

Guidelines on chest compressions for cardiac arrest may be encouraging well-meaning aid to push too far. Out-of-hospital cardiac arrest patients had best outcomes with a chest compression depth between 40.3 and 55.3 mm, according to findings published online Sept. 24 in Circulation.

Cardiologist pays $200K to settle kickback case

A cardiologist in Georgia agreed to pay $200,000 to settle a longstanding kickback case, the Atlanta U.S. Attorney’s Office announced.

Making guidelines an ally

How avidly do clinicians follow guidelines? Perhaps only to the degree that their worth is apparent and appreciated.

Lipid recommendations fill cholesterol guidelines’ black holes

The National Lipid Association published recommendations that are designed to help fill the gaps in the 2013 cholesterol guidelines jointly released by two cardiology associations. The report aligns with some aspects of the guidelines but diverges on cholesterol targets.

Debate is on: On-site vs. hospital treatment for cardiac arrest

To transport to hospital or not when an out-of-hospital cardiac arrest has no shockable rhythm was at the center of a debate published online Sept. 23 in BMJ.

Guideline updates: Goodbye NSTEMI, hello NSTE-ACS

New terms like non-ST-elevation acute coronary syndrome (NSTE-ACS) and a continuum view of unstable angina are a large part of the updated joint guidelines published Sept. 23 in Circulation. 

Statins significantly improve 30-day outcomes in ICH study

Patients on statins had a 4.25 times greater 30-day survival rate following intracranial hemorrhage (ICH) than patients who were not on statins in a study published online Sept. 22 in JAMA: Neurology. Statin use also had a significant impact on whether or not patients were sent home or to a rehabilitation facility.

Study finds 4 out of 5 MIs preventable with healthy lifestyle

Checking off all of the boxes for a healthy lifestyle could reduce the risk of MI in men by as much as 86 percent. These findings were published Sept. 30 in the Journal of the American College of Cardiology.

Generic statins increase adherence, improve outcomes

When it comes to statin adherence, cost matters. A 6 percent greater adherence was seen in patients using generic statins compared with patients on brand-name drugs, according to a study published Sept. 16 in Annals of Internal Medicine.

Variability in CAD detection questioned in invasive testing study

When clinicians are looking for stable ischemic heart disease and obstructive coronary heart disease, are they overusing invasive methods? A group of researchers wondered how frequently angiographies are diagnosing obstructive coronary heart disease. The answer: is it varies.  

SOLID-TIMI 52: Darapladib a dud for acute coronary syndrome

Acute coronary syndrome patients did not experience benefit from using darapladib in a study published Aug. 31 in JAMA.

FDA panel to rule on blood pressure combo drug

The FDA’s Cardiovascular and Renal Drug Advisory Committee will meet Sept. 9 and 10 to review a proposed treatment for hypertension and discuss other fixed-dose combinations.

Ivabradine makes no dent on mortality in patents with stable CAD

Heart patients taking ivabradine did not experience a higher survival rate over placebo in a trial published online Aug. 31 in the New England Journal of Medicine and presented at the 2014 European Society of Cardiology Congress in Barcelona. 

A world of uncertainties

Cardiologists rely on evidence from clinical trials to make treatment decisions yet the evidence may be in discord with what they encounter in practice. And in practice, they may be reluctant to stick with the selection criteria used in clinical trials.

Medtronic buys Italian managed services firm

Medtronic acquired NGC Medical for $350 million, a transaction that will give Medtronic access to cardiovascular managed services in about 30 hospitals in Italy with possible expansion in Europe, Africa and the Mideast.

Weekend nurse staffing key to improved stroke outcomes

Stroke patients admitted to specialized units on the weekend have better outcomes when there is a higher registered nurse-to-bed ratio, according to a study published Aug. 19 in PLOS Medicine.